Yiying Guo

556 total citations
26 papers, 421 citations indexed

About

Yiying Guo is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yiying Guo has authored 26 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yiying Guo's work include Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Yiying Guo is often cited by papers focused on Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Yiying Guo collaborates with scholars based in China, United States and Japan. Yiying Guo's co-authors include Junling Li, Puyuan Xing, Shouzheng Wang, Yu Xu, Shangli Cai, Fan Zhang, Yan Wang, Guoqiang Wang, Chengcheng Li and Bailin Zhang and has published in prestigious journals such as Annals of Oncology, Biochemical Pharmacology and Carcinogenesis.

In The Last Decade

Yiying Guo

25 papers receiving 418 citations

Peers

Yiying Guo
Hsiang‐Fong Kao Taiwan
Monica Capozzi Italy
Xianqiang Liu China
Marion L. Hartley United States
Danae Hamouda United States
Amandine Quivy France
Eleonora Zaccarelli Italy
François‐Xavier Danlos France
Xiaoyuan Li China
Hsiang‐Fong Kao Taiwan
Yiying Guo
Citations per year, relative to Yiying Guo Yiying Guo (= 1×) peers Hsiang‐Fong Kao

Countries citing papers authored by Yiying Guo

Since Specialization
Citations

This map shows the geographic impact of Yiying Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiying Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiying Guo more than expected).

Fields of papers citing papers by Yiying Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiying Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiying Guo. The network helps show where Yiying Guo may publish in the future.

Co-authorship network of co-authors of Yiying Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yiying Guo. A scholar is included among the top collaborators of Yiying Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiying Guo. Yiying Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Miaomiao, Yiying Guo, Yunzhang Liu, et al.. (2025). UBXD8 promotes lung cancer progression and activates the HIF-1α pathway. Biochemical Pharmacology. 240. 117078–117078.
2.
Wang, Xuerong, Yiying Guo, Chao Li, et al.. (2024). NR1D1 activation alleviates inflammatory response through inhibition of IL-6 expression in bovine endometrial epithelial cells. International Journal of Biological Macromolecules. 283(Pt 4). 137642–137642. 3 indexed citations
3.
4.
Li, Yuanliang, Yiying Guo, Zixuan Cheng, et al.. (2023). Whole-exome sequencing of rectal neuroendocrine tumors. Endocrine Related Cancer. 30(9). 5 indexed citations
5.
Guo, Yiying, et al.. (2023). Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases. Neuroendocrinology. 113(9). 943–956. 5 indexed citations
6.
Yang, Lin, Zicheng Zhang, Yibo Zhang, et al.. (2023). Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities. Pharmacological Research. 194. 106844–106844. 17 indexed citations
7.
8.
Zhang, Jinyao, Xujie Sun, Li Liu, et al.. (2022). Clinical significance of ALDH1A1 expression and its association with E-cadherin and N-cadherin in resected large cell neuroendocrine carcinoma. Translational Oncology. 19. 101379–101379. 1 indexed citations
9.
10.
Wang, Xin, Yiying Guo, Li Liu, et al.. (2021). YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes. Lung Cancer. 160. 166–174. 15 indexed citations
11.
Pang, Xiaocong, Junyun Wang, Shouzheng Wang, et al.. (2021). Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma. Frontiers in Oncology. 11. 591922–591922. 9 indexed citations
12.
Guo, Yiying, Lin Yang, Li Liu, et al.. (2020). Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection. Thoracic Cancer. 11(10). 2782–2792. 21 indexed citations
13.
Xing, Puyuan, Nong Yang, Yuxin Mu, et al.. (2020). The clinical significance of RET gene fusion among Chinese patients with lung cancer. Translational Cancer Research. 9(10). 6455–6463. 4 indexed citations
14.
Liu, Li, Fei Teng, Yixiang Zhu, et al.. (2020). Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery. Human Pathology. 108. 84–92. 10 indexed citations
15.
Liu, Li, Yiying Guo, Jinyao Zhang, et al.. (2020). Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer. Thoracic Cancer. 12(1). 40–47. 8 indexed citations
16.
Xing, Puyuan, Fan Zhang, Guoqiang Wang, et al.. (2019). Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer. 7(1). 341–341. 141 indexed citations
17.
Lv, Wenhua, Yiying Guo, Ziqi Yu, et al.. (2015). The drug target genes show higher evolutionary conservation than non-target genes. Oncotarget. 7(4). 4961–4971. 15 indexed citations
18.
Yao, Ye, Xingyu Zhang, & Yiying Guo. (2010). Experimental Study on Heat Transfer Enhancement of Water-water Shell-and-Tube Heat Exchanger Assisted by Power Ultrasonic. Purdue e-Pubs (Purdue University System). 10 indexed citations
19.
Zhang, Bailin, Tong Sun, Lei Xue, et al.. (2006). Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis. 28(5). 1067–1073. 88 indexed citations
20.
Wong, Yin Cheong, et al.. (1983). Hemoglobin Quin-Hai, β78 (Ef2) Leu→Arg, a New Abnormal Hemoglobin Found in Guangdong, China. Hemoglobin. 7(5). 407–412. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsiang‐Fong Kao Breakdown of academic impact, for papers by Monica Capozzi Breakdown of academic impact, for papers by Xianqiang Liu Breakdown of academic impact, for papers by Marion L. Hartley Breakdown of academic impact, for papers by Danae Hamouda Breakdown of academic impact, for papers by Amandine Quivy Breakdown of academic impact, for papers by Eleonora Zaccarelli Breakdown of academic impact, for papers by François‐Xavier Danlos Breakdown of academic impact, for papers by Xiaoyuan Li
Rankless by CCL
2026